Page 121 - EKMUD Erişkin Bağışıklama Rehberi 2024

Erişkin Bağışıklama Rehberi 2024

4.6.3. spesifik Bir Başka endikasyon olması durumunda Önerilen aşılar
Kronik hastalığı olan bireylerde başka risk durumları da varsa rehberin ilgili bölüm-
lerinde önerilen aşılar da uygulanır.

kaYnaklar
1. Demirci I, Haymana C, Salman S, et al. Rates and associates of influenza and pneumococcus
vaccination in diyabetes mellitus: A nationwide cross-sectional study (TEMD vaccination study).
World J Diabetes 2021;12(12):2107-18. https://doi.org/10.4239/wjd.v12.i12.2107
2. Murthy N, Wodi AP, Bernstein H, et al. Advisory committee on immunization practices recom-
mended immunization schedule for adults aged 19 years or older - United States, 2022. MMWR
Morb Mortal Wkly Rep 2022;71(7):229-33. https://doi.org/10.15585/mmwr.mm7107a1
3. Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease pre-
vention in clinical practice. Eur Heart J 2021;42(34):3227-337. https://doi.org/10.1093/eurhe-
artj/ehab484
4. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis,
Management, and Prevention of Chronic Obstructive Pulmonary Disease 2021 Report. Erişim
adresi: http:// goldcopd.org
5. Huang HH, Chen SJ, Chao TF, et al. Influenza vaccination and risk of respiratory failure in patients
with chronic obstructive pulmonary disease: A nationwide population-based case-cohort study.
J Microbiol Immunol Infect 2019;52(1):22-9. https://doi.org/10.1016/j.jmii.2017.08.014
6. Walters JA, Tang JN, Poole P, et al. Cochrane Pneumococcal vaccines for preventing pneu-
monia in chronic obstructive pulmonary disease (Review). Cochrane Database Syst Rev
2017;1(1):CD001390. https://doi.org/10.1002/14651858.CD001390.pub4

100